Clarithromycin - a common antibiotic used for treating respiratory tract infections was found to be associated with a higher risk of heart problems, says study published in BMJ. The authors say their findings require confirmation, but add to a growing body of evidence suggesting a possible link between long term cardiovascular risks and certain antibiotics, known as macrolides. Clarithromycin is often used to treat a sudden increase in symptoms ...
View the original article here
This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.
A large population of healthy people are taking Aspirin to prevent cardiovascular disease, a new study out of the Faculty of Medicine (and) Dentistry shows. This trend is prevailing despite the fact that new literature shows it is not as beneficial as once thought. Olga Szafran and Mike Kolber, in the Department of Family Medicine at the University of Alberta, surveyed patients over the age of 50 at two clinics in Alberta. They found that more than 40 per cent of people ...
Quitting smoking is associated with a reduced risk of cardiovascular diseases, finds study published in JAMA. "Cigarette smoking is the leading cause of preventable mortality in the United States and a major risk factor for cardiovascular disease (CVD). Smoking cessation substantially reduces the risks of CVD; however, quitting smoking is associated with a small number of adverse health consequences, weight gain being one of smokers' major concerns," according ...
Burnt-out employees face a higher risk of heart disease, finds study. As they try to meet their demanding careers, many workers experience job burnout - physical, cognitive, and emotional exhaustion that results from stress at work. Researchers have found that burnout is also associated with obesity, insomnia, and anxiety. Now, Dr. Sharon Toker of TAU's Faculty of Management and her fellow researchers - Profs. Samuel Melamed, Shlomo Berliner, ...
Patients who were not given aspirin before artery-clearing coronary angioplasty were found to have a significantly higher in-hospital death rate, shows research. Aspirin use before angioplasty is a Class I recommendation of the American College of Cardiology and American Heart Association, the highest level of evidence for ACC/AHA guidelines. Aspirin has well-documented anti-platelet activity in reducing the risk of cardiac events. Researchers ...
